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Membrane trafﬁckingThe T-cell protein tyrosine phosphatase is expressed as two splice variants — TC45, a nuclear protein, and
TC48, which is localized predominantly in the ER (endoplasmic reticulum). Yeast two-hybrid screening
revealed direct interaction of TC48 with Syntaxin17, a SNARE (soluble N-ethylmaleimide-sensitive factor
attachment protein receptor) protein localized predominantly in the ER and to some extent in the ER-Golgi
intermediate compartment. Syntaxin 17 did not interact with TC45. C-terminal 40 amino acids of TC48
were sufﬁcient for interaction with syntaxin 17. Overexpressed syntaxin 17 was phosphorylated at tyrosine
upon pervanadate treatment (a tyrosine phosphatase inhibitor/tyrosine kinase activator) of COS-1 cells.
Mutational analysis identiﬁed Tyr156 in the cytoplasmic domain as the major site of phosphorylation.
Endogenous syntaxin 17 was phosphorylated by pervanadate treatment in CHO and MIN6 cells but was
not phosphorylated in a variety of other cell lines tested. c-Abl was identiﬁed as one of the kinases, which
phosphorylates syntaxin 17 in MIN6 cells. Phosphorylation of endogenous and overexpressed syntaxin 17 was
reduced in the presence of IGF receptor and EGF receptor kinase inhibitors. Serum depletion reduced
pervanadate-induced phosphorylation of endogenous syntaxin 17. TC48 coexpression reduced phosphorylation
of syntaxin 17 by pervanadate and puriﬁed TC48 directly dephosphorylated syntaxin 17. β-COP dispersal by
overexpressed syntaxin 17 was reduced after pervanadate-induced phosphorylation. A phospho-mimicking
mutant (Y156E) of syntaxin 17 showed reduced interaction with COPI vesicles. These results suggest that
tyrosine phosphorylation of syntaxin 17 is likely to have a role in regulating syntaxin 17 dependent membrane
trafﬁcking in the early secretory pathway.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Phosphorylation of proteins on tyrosine residues is a critical
mechanism for the control of several signaling pathways in higher
eukaryotes including cell proliferation and differentiation, intracellu-
lar trafﬁc, signal transduction, etc. [1]. Protein tyrosine phosphatases
(PTPs) catalyze the dephosphorylation of tyrosine phosphorylated
proteins and thereby regulate their function [2–7]. Only three PTPs are
localized predominantly on internal membranes: PTP1B and TCPTP
(TC48 isoform) on the endoplasmic reticulum (ER) and PTP-MEG2 on
secretory vesicles [8–11]. Two splice variants of TCPTP are expressed in
human cells, a 48 kDa form (TC48) which is localized predominantly inotein; COPI, Coatomer protein I;
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rights reserved.the ER, and a shorter 45 kDa form (TC45) that is present in the nucleus
[9–13]. EGF receptor, insulin receptor andMet-receptor tyrosine kinases
have been identiﬁed as substrates of TC48 in the ER but they are also
dephosphorylated by TC45 at the plasma membrane [14–16]. So far
only one protein, C3G (RapGEF-1), has been identiﬁed as a speciﬁc
substrate of TC48 which is not dephosphorylated by TC45 [17].
After its synthesis in the ER, TC48 moves to the ERGIC (ER-Golgi
intermediate compartment) and Golgi complex along the secretory
pathway and its ER localization is maintained by selective retrieval
[9]. It is generally believed that the retrieval of proteins from
post-ER compartments is a mechanism of targeting of the protein to
the ER. However, it is also possible that this cycling process may
serve additional functions in post-ER compartments, for example
regulation of trafﬁcking and/or signal transduction. Some evidence
for this hypothesis is provided by the ﬁnding that Golgi localized
phosphorylated C3G is dephosphorylated by TC48 under physiologi-
cal conditions [17]. To gain insight into the function of TC48 in the
early secretory pathway and identify its substrates, we carried out a
yeast two-hybrid screening and found that it interacts with a
t-SNARE (target membrane SNARE) protein, syntaxin 17.
SNAREs are soluble N-ethylmaleimide-sensitive factor (NSF) attach-
ment protein receptors, which have an essential role in mediating
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namics in eukaryotic cells [18–23]. SNAREs can be broadly divided as
v-(vesicle membrane) or t-(target membrane) SNAREs and syntaxins
are a subgroup, which are mostly present on the target membranes
[24,25]. Syntaxin 17 is ubiquitously expressed and is present predomi-
nantly in smooth ER and ERGIC membranes where it may act as a
receptor protein [26–28]. Unlike other syntaxins, syntaxin 17 has two
hydrophobic domains and a unique 33 amino acid lumenal tail and is
highly expressed in steroidogenic cell types [27]. The function of
syntaxin 17 is still not very clear, however, it was identiﬁed as a SNARE
required for constitutive secretion in an siRNA screen [29]. Syntaxin 17
is essential to maintain the architecture of the ERGIC and Golgi [26]
whereas syntaxin 18, another ER SNARE, is required to maintain the
architecture of the ER [30]. Syntaxin 17 is also shown to be associated
with certain diseases [31,32].
In the present study we show that TC48 interacts physically with
syntaxin 17 in mammalian cells. We also show that syntaxin 17 gets
phosphorylated on Tyr156 and gets dephosphorylated by TC48. One
of the kinases to phosphorylate syntaxin 17 was identiﬁed to be c-Abl
kinase. Phosphorylation of endogenous syntaxin 17 is seen in a cell
type-speciﬁc manner and it requires serum factors. Phosphorylation of
overexpressed syntaxin 17 affected β-COP distribution in the cells.
Our results suggest that tyrosine phosphorylation of syntaxin 17 may
be involved in regulating trafﬁcking mediated by syntaxin 17.
2. Materials and methods
2.1. Cell culture and transfections
COS-1 cells and other cell lines were grown as monolayers in a
humidiﬁed atmosphere of 5% CO2 at 37 °C in Dulbecco's modiﬁed
Eagle's medium (DMEM) containing 10% FCS, 100 U/ml penicillin and
100 μg/ml streptomycin. Transfections were performed in COS-1 cells
using the cationic lipid DHDEAB as described [33,34]. Transfections in
other cell lines were performed using Lipofectamine 2000 (Invitrogen,
San Diego, CA, USA) according to the manufacturer's instructions.
2.2. Antibodies and reagents
Rabbit polyclonal anti-syntaxin 17 antibody was from Sigma (Cat
No. HPA001204). Mouse monoclonal anti-ERGIC-53 was from Axxora
Biochemicals. Rabbit polyclonal anti-Sec24C was a gift from DrWilliam
E. Balch (Scripps Research Institute, San Diego, CA, USA) and has been
described before [35]. Rabbit polyclonal anti-β-COP antibody was
from Afﬁnity Bioreagents and mouse monoclonal β-COP was from
Sigma. Anti-GAPDH antibody was from Millipore. Protein A/G plus
agarose beads, mouse monoclonal and rabbit polyclonal anti-myc anti-
bodies, agarose conjugated anti-myc antibody, anti-GFP antibodies,
mouse monoclonal anti-phosphotyrosine (pY20) antibody, anti-mouse
and anti-rabbit control IgG, mouse monoclonal anti-c-Abl antibody,
mouse monoclonal anti-GST antibody and anti-α-tubulin antibody
were from Santa Cruz. The mouse monoclonal G11 antibody, which rec-
ognizes rat TC45, TC48, overexpressed human TC45 and TC48 proteins,
has been described earlier [36]. HRP conjugated anti-mouse and anti-
rabbit IgGs and Cy3-conjugated anti-mouse and anti-rabbit IgGs were
from Amersham. Alexa-488 and Alexa-633 conjugated anti-mouse and
anti-rabbit IgGs were from Molecular Probes. EGFR inhibitor (AG1478)
and IGFR inhibitor (AG1024) were from Calbiochem. STI 571 was gift
from Natco Pharma Ltd., and sodium orthovanadate was from Sigma.
Yeast media and culture reagents were purchased from Himedia and
Sigma.
2.3. Expression vectors
GFP-TC48, GFP-C40, pGBKT7-TC48, pGBKT7-TC45, pGBKT7-ΔNLS,
pGBKT7-C66 and pGBKT7-C40 have been previously described [9].Myc-Syn17 which codes for full length rat syntaxin 17 has been de-
scribed before [27] and was kindly provided by Richard H. Scheller
(Stanford University, California, USA). Full-length syntaxin 17 was
cloned from myc-tagged plasmids to pEGFP-C2 vector in EcoR1 and
Apa1 sites to generate GFP-Syn17. Myc-Syn17 was mutated to
myc-Y156F and myc-Y156E mutant by site directed mutagenesis fol-
lowing the protocol described in QuickChange Site directed mutagen-
esis kit (Stratagene). During yeast two-hybrid screening process of
human placental cDNA library, a smaller construct of syntaxin 17 in
pACT-II (ΔNSyn17) was obtained which codes for 121–302 aa. This
cDNA was further cloned in a pcDNA3.1 vector with HA tag at the
5'-end of cDNA to generate the HA-ΔNSyn17 construct. Deletion con-
struct of human syntaxin 17, TMCT was prepared by amplifying the
region from 229 to 302 aa by PCR and cloning in the BamH1 and
Xho1 sites of pACT-II. The deletion constructs of syntaxin 17, SDTM
and NSDM were prepared by inserting a stop codon at 274 aa and
229 aa positions, respectively, using site directed mutagenesis in
pACT-II. GST-TC48 was constructed by excising full length TC48
from pMOS clone (described in [9]) with EcoR1 and Sal1 and cloned
into pGEX-5X-2 vector. Human c-Abl expression vector c-Abl-pSGT
was from Dr Richard Van Etten and has been referred earlier [37].
2.4. Yeast two-hybrid screening
Yeast two-hybrid screening was carried out using the yeast strain
PJ69-4A [38] and the full-length TC48 protein was used as bait pro-
tein. The TC48 (pGBKT-7)-expressing PJ69-4A strain was transformed
with human placental cDNA library in pACT-II vecor (Clontech). The
procedure followed has been described previously [9]. The interac-
tions were conﬁrmed by retransformation of positive clones with
TC48 or control plasmids by plating on yeast dropout medium lacking
Trp, Leu and Ade. The interaction was also tested by the activation of
β-galactosidase reporter gene by plating them on plates containing Trp
and Leu dropout medium (adjusted to pH 7.0) and β-galactosidase
substrate.
2.5. Indirect immunoﬂuorescence and confocal microscopy
For immunoﬂuorescence COS-1 cells were grown on coverslips,
transfected with required plasmids and ﬁxed after 24 h. The cells were
then immunostainedwith required antibodies. Indirect immunostaining
of cells was carried out as described earlier [9,39]. Colocalization was
determined by observing the staining patterns, with the LSM 510 Meta
NLO Confocal Microscope from Carl Zeiss. Serial optical sections in the
Z-axis of the cell were collected at 0.33 μm intervalswith 63× oil immer-
sion objective lens (NA 1.4). Then, two middle optical sections were
projected and colocalization was observed by using LSM 510 (version
3.2) software. Quantiﬁcation analysis of co-localization was done by cal-
culating Pearson's correlation coefﬁcients using LSM 510 software.
2.6. Co-immunoprecipitation and western blotting
For co-immunoprecipitation, cells in 60-mm dishes were trans-
fected with required plasmids and after 36 h, cells were washed
with ice-cold PBS and then lysed at 4 °C for 20 min in lysis buffer
containing 25 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1.0% Triton X-100,
1 mM PMSF, 0.1% BSA, 5 mM EDTA and protease inhibitor cocktail
(Roche Biochemicals). Lysates were centrifuged at 10,000 rpm for
12 min at 4 °C and the supernatant was used for immunoprecipitation
using 2 μg of antibody or 2 μg of normal IgG as control antibody. Super-
natants were either incubated overnight with antibodies and then 20 μl
protein A/G plus agarose beads were added for another hour at 4 °C or
the supernatants were incubated with antibody conjugated agarose
beads for 4 h at 4 °C. Then the beads containing immune complexes
were given three washes in wash buffer (20 mM Hepes pH 7.4, 0.1%
Triton X-100, 150 mM NaCl, 10% glycerol, 1 mM PMSF, and protease
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In case immunoprecipitations were done for phosphorylated proteins,
2 mM sodium orthovanadate and 10 mM sodium ﬂuoride were added
in lysis buffer and wash buffer. The samples were resolved in SDS-
PAGE and transferred to nitrocellulose membrane for western blot
analysis. Western blotting was performed using standard protocols as
described earlier [9].
2.7. In vitro dephosphorylation assay
GST and GST-TC48 were expressed in E. coli strain BL21 and were
puriﬁed using glutathione-Sepharose beads and eluted with neutral-
ized reduced glutathione. Enzymatic activity of GST-TC48 was deter-
mined by using artiﬁcial tyrosine phosphatase substrate, para-
nitrophenyl phosphate (pNPP). GST-TC48 or GST were incubated
with 5 mM pNPP in 50 mM Tris–HCl (pH 7.1) reaction buffer at
30 °C for 5–10 min in a volume of 100 μl and then the reaction was
stopped by adding 1 ml of 2 M sodium carbonate and absorbance
was measured at 430 nm [40]. COS-1 cells were transfected with
myc-Syn17 and after 36 h of expression, tyrosine phosphorylation
of syntaxin 17 was stimulated by treating the cells with 0.1 mM
pervanadate for 20 min. Then syntaxin 17 was immunoprecipitated
with agarose conjugated anti-myc antibody. The immune complexes
were washed twice with wash buffer and once with dephosphoryla-
tion assay buffer [50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 5 mM
DTT, 0.02% Triton-X 100 and 0.2 mM EDTA] and incubated with either
GST-TC48 or GST proteins in dephosphorylation buffer at 30 °C for
15 min. The reaction was stopped by adding 3× SDS-PAGE sample
buffer.
2.8. Pervanadate treatment
Cellswere subjected to pervanadate treatment by addition of freshly
prepared 0.1 mM solution of pervanadate for required time prior to
harvesting as described earlier [34]. Pervanadate stock solution
(50 mM) was prepared by mixing equal volumes of 100 mM solution
of H2O2 and 100 mM solution of sodium orthovanadate.
2.9. Statistical analysis
Graphs were represented as average±SD values. Differences
between averages were tested using Student's t test. P values obtained
less than 0.05 were considered signiﬁcant. In pair wise comparisons p
values were denoted as *, **, or *** in the graphs based on whether
they were less than 0.05, 0.01 or 0.001, respectively.
3. Results
3.1. Identiﬁcation of Syntaxin 17 as TC48-interacting protein
To understand the functional signiﬁcance of presence of TC48 in
early secretory pathway and identify its interacting partners we
carried out yeast two-hybrid screening using full length TC48 as
bait. One of the positives identiﬁed as TC48-interacting protein
was syntaxin17. The cDNA clone obtained codes for aa 121–302 of
human syntaxin 17, which encompasses N-terminal cytoplasmic
domain partially, the conserved SNARE domain, the two hydrophobic
domains and the unique C-terminal lumenal domain. The interaction
of syntaxin 17 with TC48 was speciﬁc as it did not interact with the
other splice variant TC45 or with the N-terminal catalytic region,
which is common in TC48 and TC45, or with the protein expressed
by control plasmid pGBKT7 (Fig. 1A). In TC48, the last 6 amino acids
of TC45 are replaced by 34 mostly hydrophobic amino acids [11,12].
This suggests that it is the C-terminal hydrophobic region of TC48
that interacted with syntaxin 17. We further determined that the
C-terminal 40 aa were actually sufﬁcient for interaction with syntaxin17 by using two deletion constructs of TC48, C-66 (C-terminal 66 aa)
and C-40 (C-terminal 40 aa) (Fig. 1A and B). Similarly, different dele-
tion constructs of syntaxin 17 were made to determine the domains
required for interaction with TC48. The truncated construct of
syntaxin 17, which lacked the C-terminal tail (121–273 aa — SDTM),
showed somewhat weaker interaction with TC48 as it showed
delayed growth on Ade deﬁcient plates (Fig. 1C and D). The construct
of syntaxin 17, which lacked the C-terminal tail as well as both the
hydrophobic domains (121–228 aa — NSDM), did not interact with
TC48. The TMCT construct (227–302 aa), which had only the two
hydrophobic domains and the C-terminal tail, also did not show inter-
action with TC48 (Fig. 1C and D). This suggests that the hydrophobic
domains of syntaxin 17 were required but not sufﬁcient for interac-
tion with TC48.
We next examined the interaction of TC48 and syntaxin 17 in
mammalian cells. The plasmids expressing GFP tagged full length
human TC48 and myc tagged full length rat syntaxin 17 (myc-Syn17)
were coexpressed in COS-1 cells; after 36 h cell lysates were prepared
and immunoprecipitation was carried out using either myc antibody
or control antibody. Western blot analysis showed the presence of
TC48 in the immunoprecipitate with myc antibody but not in the
immunoprecipitate with control antibody (Fig. 1E). This result
showed that overexpressed TC48 and syntaxin 17 interacted with
each other. We also examined the interaction of TC48 with endoge-
nous syntaxin 17. First we analyzed the expression of endogenous
syntaxin 17 in some commonly used mammalian cell lines using a
commercial antibody from Sigma. Endogenous syntaxin 17 was
detectable as a 38 kDa major band with this antibody in COS-1, HeLa,
HepG2, A549 and HEK293 cells whereas over-expressed syntaxin 17
showed slower mobility due to the addition of myc tag (Fig. 1F).
GFP-TC48 was overexpressed in COS-1 cells for 36 h and immunopre-
cipitation was carried out with GFP antibody or control antibody.
Endogenous syntaxin 17 was detected in the immunoprecipitate with
GFP antibody but not with control antibody (Fig. 1G). To examine the
interaction of endogenous syntaxin 17 with endogenous TC48 we
used CHO cell line as the antibodies against both the proteins worked
in this cell line. CHO cell lysates were subjected to immunoprecipitation
using G11 antibody, which recognizes both isoforms of TCPTP [36],
followed by western blotting. Endogenous syntaxin 17 was detected
in the immunoprecipitate with G11 antibody but not with control anti-
body (Fig. 1H). This suggested that endogenous syntaxin 17 interacted
with endogenous TC48; this interaction was probably not with TC45
isoform as we showed that syntaxin 17 interacted speciﬁcally with
TC48 isoform and not with TC45 in yeast two-hybrid assay.
3.2. TC48 colocalizes with syntaxin 17
Since TC48 interacts with syntaxin 17 we examined the possibility of
their colocalization in mammalian cells. GFP-TC48 when coexpressed
withmyc-Syn17 in COS-1 cells showed colocalization in someperinuclear
areas of the cell (Fig. 2A). GFP-TC48 also showed colocalization with
endogenous syntaxin 17 in COS-1 cells (Fig. 2B). Since syntaxin 17 is
present in the ER as well as ERGIC, we dual-stained GFP-TC48 expressing
cells with antibodies that recognize ERGIC-53, a marker for ERGIC, along
with endogenous syntaxin 17. TC48 colocalized with syntaxin 17 in
ERGIC and outside ERGIC (Fig. 2B). These results suggest TC48 and
syntaxin 17 colocalize in the ER as well as ERGIC.
3.3. Syntaxin17 gets phosphorylated on tyrosine
Interaction of syntaxin 17 with TC48 tyrosine phosphatase led us
to investigate the possibility of its regulation by tyrosine phosphory-
lation. Myc-Syn17 was overexpressed in COS-1 cells and after 30 h
the cells were either treated with 0.1 mM pervanadate for 20 min
or left untreated. Pervanadate is an inhibitor of protein tyrosine
phosphatases and an activator of some protein tyrosine kinases.
Fig. 1. Interaction of TC48 with syntaxin 17. A. The yeast strain PJ69-4A was transformed with the pairs of indicated expression plasmids expressing hybrid proteins fused to the
GAL4-DNA-binding domain (TC48 or TC45 or Δ-NLS or control vector pGBKT7, C) and to the GAL4-activation-domain (syntaxin 17 cloned in pACTII) (upper panels). The yeast strain
was cotransformed with syntaxin 17 and TC48 or its deletion constructs, C-66 and C-40 (lower panels). Transformants were plated on medium without (Ade−) or with (Ade+)
adenine. Growth in the absence of adenine indicates the interaction between hybrid proteins. Each patch represents an independent transformant. Transformants were also
grown on plates supplemented with β-galactosidase substrate X-gal (X-gal+) as lacZ is an additional reporter gene. Blue color development of colonies indicates interaction
between the two proteins. B. Schematic representation of TC48, TC45 and their deletion constructs. C. Yeast strain PJ69-4A was co-transformed with TC48 (cloned in pGBKT-7)
and various mutants of syntaxin 17. Transformants were grown on plates with (Ade+) or without adenine (Ade−). D. Schematic representation of syntaxin 17 and its deletion
constructs. E. Interaction of overexpressed Syntaxin 17 and TC48. COS-1 cells cotransfected with GFP-TC48 and myc-Syn17 plasmids were subjected to immunoprecipitation
using myc antibody or control antibody. Immunoprecipitates were analyzed by western blotting. F. Western blot shows expression of endogenous syntaxin 17 in mammalian
cell lines. CDK2 is a loading control. G. Interaction of endogenous syntaxin 17 with GFP-TC48. COS-1 cells were transfected with GFP-TC48 and immunoprecipitation was carried
out using GFP antibody or control antibody. The immunoprecipitates were analyzed by western blotting. H. Interaction of endogenous syntaxin 17 with endogenous TC48. CHO
cell lysates were subjected to immunoprecipitation using G11 antibody or control antibody and resolved in SDS-PAGE and analyzed by western antibody using syntaxin 17 and
G11 antibodies.
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Fig. 2. Colocalization of syntaxin 17 with TC48. A. GFP-TC48 and myc-Syn17 were cotransfected in COS-1 cells. Cells were ﬁxed after 24 h and immunostained with myc antibody
followed by Cy3-conjugated secondary antibody (red) and observed by confocal microscopy. Yellow color generated in the merged image shows colocalization of TC48 with
syntaxin 17. B. GFP-TC48 was transfected in COS-1 cells and after 24 h cells were ﬁxed and immunostained with syntaxin 17 antibody followed by Cy3-conjugated secondary
antibody (red) and ERGIC-53 antibody followed by Alexa-633-conjugated secondary antibody (blue). Colocalization was analyzed by confocal microscopy. Scale bar: 10 μm.
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western blot analysis using an anti-phospho-tyrosine monoclonal
antibody showed a band at 45 kDa in the immunoprecipitate from
pervanadate treated cells but not from the untreated cells (Fig. 3A).
When this blot was reprobed with anti-myc antibody, two bands were
visible in the pervanadate treated immunoprecipitate compared to single
band in the untreated sample. The slower migrating band (myc blot)
corresponded to the 45 kDa band detected in the phosphotyrosine blot.
These results suggest that syntaxin 17 gets phosphorylated on tyrosine
and phosphorylated syntaxin 17 shows slower mobility than the
non-phosphorylated form in SDS-PAGE.Syntaxin17 has 3 tyrosines and bioinformatic analysis using Scansite
Motif Scan suggested that Tyr-156 of rat syntaxin 17 (Tyr-157 in human
protein) was most likely to be the site of phosphorylation. We created
Y156F mutant of full-length rat syntaxin 17 by site directed mutagene-
sis. COS-1 cells were transfected with Y156F-Syn17 mutant and treated
with pervanadate. Y156F–Syn17 did not show any mobility shift in
pervanadate treated cells (Fig. 3B) suggesting, therefore, that Tyr-156
is the major site of phosphorylation in syntaxin 17. Moreover Y156F–
Syn17 showed slightly faster mobility than wild type syntaxin 17.
Tyrosine at 156 positionwas found to be conserved in variousmamma-
lian species (Fig. 3C).
Fig. 3. Syntaxin 17 gets phosphorylated on tyrosine. A. COS-1 cells were transfected with myc-Syn17 and after 30 h, cells were either treated with 0.1 mM pervanadate for 20 min
or left untreated. Immunoprecipitation of cell lysates was carried out using myc antibody followed by western blotting using indicated antibodies. pY20, phosphotyrosine antibody.
B. Syntaxin 17 gets phosphorylated on Tyr-156. COS-1 cells transfected with myc-Syn17 or its mutant, myc-Y156F-Syn17, were treated with 0.1 mM pervanadate for 20 min and
cell lysates were analyzed by western blotting. C. Sequences of syntaxin 17 from various mammalian species were aligned manually. Conserved tyrosine of syntaxin 17 is shaded.
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phorylate syntaxin 17. Pervanadate is known to activate several tyro-
sine kinases including c-Abl. Bioinformatic analysis predicted that
c-Abl was likely to phosphorylate Tyr-156 of rat syntaxin 17. There-
fore c-Abl was transfected with myc-Syn17 and the cells were treated
with H2O2 (an activator of c-Abl) or left untreated. Western blot anal-
ysis showed that c-Abl could phosphorylate syntaxin 17 as seen by
the appearance of the shifted band (Fig. 4A). This phosphorylation
increased when c-Abl was activated by treatment of cells with H2O2
(Fig. 4A). The Y156F mutant of syntaxin 17 was not phosphorylated
by c-Abl (Fig. 4A). c-Abl interacted with syntaxin 17 as determined
by co-immunoprecipitation (Fig. 4B), which suggested that c-Abl
directly phosphorylated syntaxin 17. Phosphorylation induced by
c-Abl was reduced when cells are treated with STI571 (c-Abl kinase
inhibitor) prior to the treatment of cells with H2O2 (Fig. 4C). Treatment
of the cells with EGFR kinase inhibitor (AG1478) or IGFR kinase inhib-
itors (AG1024) reduced phosphorylation of syntaxin 17 induced by
pervanadate treatment of the cells (Fig. 4D) indicating that there are
other tyrosine kinases involved in tyrosine phosphorylation of syntaxin
17. These results suggest that c-Abl is one of the tyrosine kinases, which
can phosphorylate syntaxin 17.
3.3.1. Phosphorylation of endogenous syntaxin 17 and its dependence on
serum factors
To analyze the phosphorylation of endogenous syntaxin 17,
various cell lines were treated with pervanadate. A band of slower
mobility corresponding to phosphorylated syntaxin 17 was seen
after pervanadate treatment in CHO cells (Fig. 5A) but not in many
other cell lines tested (Fig. 5C; data not shown for Huh7 and THP1
cells). Increase in phosphorylation of syntaxin 17 in CHO cells was
seen when time of pervanadate treatment was increased (Fig. 5A).
Phosphorylation of endogenous syntaxin 17 in CHO cells was reduced
when cells were treated with IGFR and EGFR kinase inhibitors prior to
pervanadate treatment (Fig. 5B) as it was seen with overexpressedsyntaxin 17 in COS-1 cells, though no reduction in phosphorylation
was seen when cells were pre-treated with c-Abl kinase inhibitor
(STI571). Since growth factors are present in serum, we examined
the effect of serum starvation on pervanadate-induced phosphoryla-
tion of syntaxin 17. Phosphorylation of endogenous syntaxin 17
was reduced when CHO cells were serum starved for 4 h prior to
pervanadate treatment (Fig. 5D). In addition to CHO cells, MIN6 cell
line (a mouse pancreatic beta cell line) showed phosphorylation of
endogenous syntaxin 17 (Fig. 6A). But, in MIN6 cells, pre-treatment
with STI571 reduced the phosphorylation of syntaxin 17 (Fig. 6B).
However, the extent of reduction was less when compared to
pre-treatment with IGFR inhibitor, and signiﬁcant reduction of phos-
phorylation was not seen when pre-treated with EGFR inhibitor
(Fig. 6B). Overexpressed c-Abl kinase phosphorylated endogenous
syntaxin 17 in MIN6 cells after activation with H2O2 (Fig. 6C). Only
slight reduction in phosphorylation of syntaxin 17 was seen upon
serum starvation in MIN6 cells (Fig. 6D). These results suggested
that phosphorylation of syntaxin 17 occurs in a cell type-speciﬁc
manner, and is mediated by growth factor receptor kinases and
c-Abl in different cell types.
3.4. Syntaxin 17 is a substrate of TC48
Since syntaxin 17 directly interacts with TC48, it may be a substrate
of TC48. To test this hypothesis, in vitro dephosphorylation assay was
carried out using puriﬁed recombinant GST-TC48 (Fig. 7A), which
exhibited catalytic activity against artiﬁcial substrate, para-nitrophenyl
phosphate (data not shown). COS-1 cells overexpressing myc-Syn17
were given pervanadate treatment for 20 min and immunoprecipitation
was carried out using agarose-conjugated myc antibody. Puriﬁed
GST-TC48 fusion protein or control GST proteinwas added to the immune
complexes and the dephosphorylation assay was carried out at 30 °C for
15 min. The reaction was stopped by adding SDS sample buffer and the
samples were analyzed by western blotting using phosphotyrosine
Fig. 4. Phosphorylation of syntaxin 17 by c-Abl kinase. A. Western blot shows phosphorylation of syntaxin 17 on Tyr-156 by overexpression and activation of c-Abl. COS-1 cells
cotransfected with myc-Syn17 or myc-Y156F-Syn17 mutant with c-Abl were kept untreated or treated with 1 mM H2O2 for 30 min. The cell lysates were analyzed by western
blotting. UT, untreated B. Syntaxin 17 interacts with c-Abl kinase. COS-1 cells cotransfected with myc-Syn17 and c-Abl treated with 1 mM H2O2 for 30 min and subjected to immu-
noprecipitation using myc antibody followed by western blotting using indicated antibodies. C. c-Abl inhibitor inhibits phosphorylation of syntaxin 17 induced by overexpression of
c-Abl. COS-1 cells transfected with myc-Syn17 alone were either kept untreated or treated with 0.1 mM pervanadate for 20 min; myc-Syn17 and c-Abl cotransfected cells were
either left untreated or given a pretreatment with DMSO or 10 μM STI571 for 2 h followed by 30 min treatment with 1 mM H2O2. D. EGFR and IGFR inhibitors reduce phosphor-
ylation of myc-Syn17 induced by pervanadate. COS-1 cells transfected with myc-Syn17 were treated with 0.1 mM of pervanadate for 5 min with or without pretreatment with
DMSO, AG1478 (EGFR inhibitor) or AG1024 (IGFR inhibitor) for 2 h. Immunoblotting was done using myc antibody, pY20 and tubulin antibodies. pY20, phosphotyrosine antibody.
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resulted in complete dephosphorylation of phosphorylated syntaxin 17,
whereas incubation with GST did not (Fig. 7B). This result shows that
syntaxin 17 is a direct substrate of TC48. If syntaxin 17 is a substrate of
TC48, then coexpression of TC48 is expected to decrease phosphorylation
of syntaxin 17 in the cells. To test this hypothesis myc-Syn17 was
expressed with and without TC48 and the cells were treated with
pervanadate. Western blot analysis showed that the level of slower mi-
grating band of syntaxin 17 decreased in TC48 expressing cells (Fig. 7C).
3.5. Effect of syntaxin 17 phosphorylation on COPI vesicles
Recently, we have shown that overexpression of syntaxin 17
affects the staining pattern of β-COP (COPI vesicle marker) from tight
juxtanuclear staining to diffuse cytoplasmic staining in majority of the
cells [26]. We determined the effect of tyrosine phosphorylation of
syntaxin 17 on COPI vesicle distribution by treating the cells with
pervanadate. Analysis of pervanadate treated myc-Syn17 expressing
cells showed that staining of β-COP (a marker for COPI vesicles) was
undisturbed in approximately 42% of the cells whereas in the control
set in 23% of the expressing cells, β-COP staining was not disturbed
(Fig. 8A and C). Pervanadate treatment of cells did not affect subcellular
localization of Y156F-Syn17 mutant and beta-COP distribution in
Y156F-Syn17 expressing cells (Fig. 8B and C). These results suggest
that tyrosine phosphorylated syntaxin 17 is unable to redistribute or
disrupt COPI vesicles. To further understand the role of phosphorylation
of Tyr-156 of syntaxin 17 on distribution of COPI vesicles we generated
a phospho-mimicking mutant of syntaxin 17, Y156E-Syn17. We ob-
served that 29% of cells expressing Y156E-Syn17 mutant showed intactβ-COP staining as compared to 21% of wild-type syntaxin 17 expressing
cells (Fig. 8D).
3.6. A phospho-mimicking mutant of syntaxin 17 (Y156E) shows altered
interaction with β-COP
Previously we have shown that overexpressed syntaxin 17 inter-
acts with β-COP [26], a component of COP1 vesicles. The interaction
of Y156E-Syn17 mutant with β-COP was examined in transfected
cells by immunoprecipitation. Compared to wild-type syntaxin 17,
the Y156E-Syn17 mutant showed reduced interaction with β-COP
whereas no difference in interaction with Sec24C (ER-exit site and
COPII vesicle component) was observed (Fig. 8E). This result provides
support to our suggestion that the phosphorylation of syntaxin 17
affects its ability to interact with COPI vesicles.
4. Discussion
The TC48 tyrosine phosphatase is predominantly localized to the ER.
It has been shown previously that TC48 cycles between the ER and
post-ER compartments [9]. The functions attributed to TC48 in the ER
are dephosphorylation of EGFR, IR and Met-receptor tyrosine kinases,
which are also the substrates of its other splice variant, TC45 [14–16].
Phosphorylated C3G localized in the Golgi is dephosphorylated by
TC48 but not by TC45 [17]. However, the function of TC48 in regulation
of intracellular vesicle trafﬁcking or vesicular trafﬁcking in the early
secretory pathway is yet to be explored. Here,we have identiﬁed syntaxin
17, a SNARE protein present mainly in the ER, as a TC48-interacting pro-
tein. This interaction is mediated by C-terminal non-catalytic sequence
Fig. 5. Phosphorylation of endogenous syntaxin 17 in CHO cells. A. CHO cells with were either treated with 0.1 mM pervanadate treatment for 10–60 min or left untreated (UT)
after which lysates were prepared and separated on SDS-PAGE. Immunoblotting was done using syntaxin 17 and GAPDH antibodies. B. Effect of IGFR and EGFR inhibitors on phos-
phorylation of syntaxin 17 in CHO cells. CHO cells were treated with 0.1 mM of pervanadate for 30 min with or without pretreatment with DMSO, AG1024 (IGFR inhibitor) AG1478
(EGFR inhibitor) or STI571 (c-Abl kinase inhibitor) for 1 h. Immunoblotting was done using syntaxin 17 and GAPDH antibodies. C. Endogenous syntaxin 17 does not get phosphor-
ylated in many cell lines. Cell lysates of untreated or 0.1 mM pervanadate treated from indicated cells were separated on SDS-PAGE and subjected to western blotting using syntaxin
17, GAPDH and pY20 antibodies. pY20, phosphotyrosine antibody. The numbers below syntaxin 17 blot indicate percentage of syntaxin 17 in the upper band. D. Phosphorylation of
syntaxin 17 is dependent on serum factors. CHO cells were either serum starved for 4 h or left untreated and then treated with 0.1 mM pervanadate for 30 min. Cell lysates were
prepared and subjected to western blotting using syntaxin 17, GAPDH and pY20 antibodies. pY20, phosphotyrosine antibody.
Fig. 6. Phosphorylation of endogenous syntaxin 17 in MIN6 cells. A. MIN6 cells were either treated with 0.1 mM pervanadate for 5–40 min or left untreated (UT) after which lysates
were prepared and separated on SDS-PAGE. Immunoblotting was done using syntaxin 17 antibody. B. Effect of IGFR, EGFR and c-Abl kinase inhibitors on phosphorylation of
syntaxin 17 in MIN6 cells. MIN6 cells were treated with 0.1 mM of pervanadate for 15 min with or without pretreatment with DMSO, AG1024 (IGFR inhibitor) AG1478 (EGFR in-
hibitor) or STI571 (c-Abl kinase inhibitor) for 1 h. Immunoblotting was done using syntaxin 17 and GAPDH antibodies. The numbers below syntaxin 17 blot indicate percentage of
syntaxin 17 in the upper band. C. Activation of overexpressed c-Abl kinase by H2O2 induces phosphorylation of syntaxin 17 in MIN6 cells. Cells were transfected with a plasmid
expressing c-Abl. After 36 h cells overexpressing c-Abl kinase were either left untreated or were treated with 1 mM H2O2 for 30 min following which cell lysates were prepared.
These cell lysates were analyzed by western blotting using syntaxin 17 and GAPDH antibodies. D. Dependence of phosphorylation of syntaxin 17 on serum factors in MIN6 cells.
Cells were either serum starved for 4 h or left untreated and then treated with 0.1 mM pervanadate for 15 min. Cell lysates were prepared and subjected to western blotting
using syntaxin 17 and GAPDH antibodies.
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Fig. 7. Syntaxin 17 is a substrate of TC48. A. GST-TC48 and GST proteins were expressed in E. coli cells and the puriﬁed proteins were checked by SDS-PAGE followed by Coomassie
blue staining. B. COS-1 cells transfected with myc-Syn17 were treated with 0.1 mM pervanadate for 20 min and immunoprecipitated using myc antibody and then subjected to
dephosphorylation assay with puriﬁed GST-TC48 or GST. The samples were separated by SDS-PAGE and analyzed by western blotting. C. Coexpression of TC48 reduced
pervanadate-induced phosphorylation of myc-Syn17. COS-1 cells transfected with myc-Syn17 alone or with GFP-TC48 were treated with 0.1 mM pervanadate for 10 min or
kept untreated. The cell lysates were analyzed by western blotting using indicated antibodies.
2117M. Muppirala et al. / Biochimica et Biophysica Acta 1823 (2012) 2109–2119of TC48,which is also involved in its trafﬁcking through post-ER compart-
ments and retrieval/targeting to the ER [9]. Our results also show that
TC48 is able to dephosphorylate syntaxin 17 phosphorylated at tyrosine.
Since TC48 shows colocalization with syntaxin 17 in and around ERGIC,
this interaction may serve the purpose of anchoring or targeting TC48 to
specialized domains of ER and/or ERGIC.
Interaction of syntaxin 17 with TC48 tyrosine phosphatase led us to
investigate the possibility of syntaxin 17 regulation by tyrosine phos-
phorylation. In this study, we present evidence for tyrosine phosphoryla-
tion of syntaxin 17. Overexpressed syntaxin 17 gets phosphorylated at
tyrosine by endogenous kinases in pervanadate treated cells and by
overexpression of c-Abl tyrosine kinase. We have identiﬁed that Tyr156
of rat syntaxin 17 as the predominant site of phosphorylation by muta-
genesis. Our results show that recombinant GST-TC48 dephosphorylated
syntaxin 17 in vitro and coexpression of TC48 in mammalian cells
reduced pervanadate-induced phosphorylation of syntaxin 17. This
suggested that syntaxin 17 not only interacts with TC48 but also acts as
a substrate for TC48. Endogenous syntaxin 17 showed phosphorylation
speciﬁcally in CHO and MIN6 cells and it did not show phosphorylation
in many other cell lines. This suggests that tyrosine phosphorylation of
endogenous syntaxin 17 is tightly regulated and is probably cell type
speciﬁc. IGFR kinase inhibitor reduced phosphorylation of endogenous
syntaxin 17 in both the cell lines (CHO and MIN6), but Abl kinase
inhibitor reduced phosphorylation only in MIN6 cells, and EGFR kinase
inhibitor reduced phosphorylation in CHO cells. This suggests that phos-
phorylation of syntaxin 17 is mediated by different kinases in different
cell types.
The phosphorylation of syntaxin 17 may affect its interaction with
components or regulators ofmembrane vesicle trafﬁcking. This hypoth-
esis is supported by theﬁnding that pervanadate-induced phosphoryla-
tion of syntaxin 17 at Tyr156 resulted in reduced dispersion of β-COP
staining (COPI vesicles marker). In addition, a phospho-mimicking
mutant of syntaxin 17 shows reduced interaction with COPI vesicles.
These results are consistent with the suggestion that tyrosine phosphor-
ylation of syntaxin 17 may be involved in regulating trafﬁcking in the
early secretory pathway. Since TC48 could dephosphorylate syntaxin
17, it may be involved in regulating the tyrosine phosphorylation-
dependent functions of syntaxin 17.
SNAREs are known to undergo various posttranslational modiﬁca-
tions including sumoylation, ubiquitination, palmitoylation, prenylation
and others [41–49]. The posttranslational modiﬁcations of proteins byserine/threonine phosphorylations have been shown to have a profound
effect on intracellular trafﬁcking [50–52]. There are only few reports
which show involvement of tyrosine phosphorylation in regulation of
intracellular vesicle transport. Tyrosine phosphorylation of Munc18C,
the negative regulator of syntaxin 4, results in disruption of Munc18C-
Syntaxin 4 complexwhich stimulates vesicle exocytosis in 3T3L1 adipo-
cytes [53,54]. Tyrosine phosphorylation of NSF prevents its binding to
α-SNAP [55]. NSF and α-SNAP binding is necessary for dissociation of
cis-SNARE complexes to promote fusion events. Dephosphorylation of
NSF by PTP-MEG2 (secretory vesicle tyrosine phosphatase) activated
NSF and promoted the fusion of syntaxin 6-containing secretory vesi-
cles [55]. PTP1B is also shown to dephosphorylate and positively mod-
ulate NSF in human sperms which results in elicitation of cis-SNARE
complex disassembly during sperm exocytosis [56]. In vitro studies
have shown that tyrosine phosphorylation state of NSF-related protein,
p97, plays a regulatory role in transitional ER assembly. JAK2 (intracel-
lular non-receptor tyrosine kinase) and PTPH1 (non-receptor PTPase)
have been identiﬁed as the relevant regulators of p97 [57]. Thus very
little is known about the involvement of tyrosine phosphorylation in
the early secretory pathway. Our results showing tyrosine phosphoryla-
tion of syntaxin 17 provide a basis for further exploring the role of this
post-translational modiﬁcation and the tyrosine kinases and PTPases in
controlling membrane trafﬁcking between ER and Golgi.
5. Conclusions
In conclusion, our results show that syntaxin 17 is phosphorylated
at tyrosine 156, a site close to the SNARE domain. Phosphorylation of
endogenous syntaxin 17 is dependent on cell type and is mediated by
c-Abl and growth factor receptor kinases. Syntaxin 17 directly inter-
acts with the tyrosine phosphatase TC48 and it is a substrate of
TC48. Our results raise the possibility of a role for tyrosine phosphor-
ylation in regulating vesicle trafﬁcking in the early secretory pathway.
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